Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1918 1
1919 1
1950 1
1951 2
1952 2
1957 1
1968 1
1969 1
1973 1
1977 1
1983 2
1993 1
1998 2
1999 2
2000 2
2005 1
2006 1
2007 3
2008 3
2009 3
2010 2
2011 3
2012 4
2013 6
2014 3
2015 7
2016 10
2017 7
2018 9
2019 9
2020 16
2021 15
2022 16
2023 9
2024 17
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Makhloufi S, Mellon G, de Lastours V, Bouchand F, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Perronne C, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia Short Treatment (PTC) Study Group. Dinh A, et al. Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. Lancet. 2021. PMID: 33773631 Clinical Trial.
Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial.
Dinh A, Duran C, Ropers J, Bouchand F, Deconinck L, Matt M, Senard O, Lagrange A, Mellon G, Calin R, Makhloufi S, de Lastours V, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia short treatment (PTC) study group. Dinh A, et al. Clin Microbiol Infect. 2024 Aug;30(8):1020-1028. doi: 10.1016/j.cmi.2024.05.003. Epub 2024 May 9. Clin Microbiol Infect. 2024. PMID: 38734138 Free article. Clinical Trial.
Embolization of the middle meningeal artery for the prevention of chronic subdural hematoma recurrence in high-risk patients: a randomized controlled trial-the EMPROTECT study protocol.
Shotar E, Mathon B, Rouchaud A, Mounayer C, Salle H, Bricout N, Lejeune JP, Janot K, Zemmoura I, Naggara O, Roux A, Goutagny S, Guedon A, Brunel H, Troude L, Dufour H, Bernat AL, Tuilier T, Bresson D, Apra C, Fouet M, Escalard S, Chauvet D, Baptiste A, Lebbah S, Dechartres A, Clarençon F; EMPROTECT collaboration. Shotar E, et al. J Neurointerv Surg. 2024 Dec 26;17(e1):e172-e177. doi: 10.1136/jnis-2023-021249. J Neurointerv Surg. 2024. PMID: 38307722
Meningeal Embolization for Preventing Chronic Subdural Hematoma Recurrence After Surgery: The EMPROTECT Randomized Clinical Trial.
Shotar E, Mathon B, Salle H, Rouchaud A, Mounayer C, Bricout N, Lejeune JP, Janot K, Amelot A, Naggara O, Roux A, Goutagny S, Guédon A, Houdart E, Brunel H, Hak JF, Troude L, Dufour H, Bernat AL, Tuilier T, Bresson D, Apra C, Fouet M, Escalard S, Chauvet D, Premat K, Lebbah S, Dechartres A, Clarencon F; EMPROTECT Investigators. Shotar E, et al. JAMA. 2025 Jul 8;334(2):127-135. doi: 10.1001/jama.2025.7583. JAMA. 2025. PMID: 40471557 Clinical Trial.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Streamlining malaria prevention recommendations for travellers: current and future approaches.
McGuinness SL, Veit O, Angelin M, Antonini P, Boecken G, Boering M, Bühler S, Calleri G, Éperon G, Flaherty G, Gossner C, Askling HH, Holmberg V, Kuenzli E, Landry P, Lefevre E, Libman M, Longley N, Maniewski-Kelner U, Neumayr A, Rapp C, Ridpath AD, Rodriguez-Valero N, Rosdahl A, Rosenbusch D, Rossanese A, Rothe C, Schlagenhauf P, Soentjens P, Staehelin C, Visser J, Visser L, Wagner A, Walker A, Wiedermann U, Wroczynska A, Hatz C. McGuinness SL, et al. Among authors: lefevre e. J Travel Med. 2024 Dec 10;31(8):taae113. doi: 10.1093/jtm/taae113. J Travel Med. 2024. PMID: 39167759 No abstract available.
Clinically silent indolent T-cell leukemia.
Janot C, Feriel J, Borie C, Lefevre E, Bennaceur-Griscelli A, Turhan AG, Aumont C. Janot C, et al. Among authors: lefevre e. Clin Case Rep. 2018 Nov 10;7(1):24-26. doi: 10.1002/ccr3.1528. eCollection 2019 Jan. Clin Case Rep. 2018. PMID: 30656001 Free PMC article.
149 results